Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range

ST. LOUIS, July 28, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 second quarter net income attributable to Express Scripts stockholders of $600.1 million, or $0.88 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.44 for the second quarter. 1

"It is clear many companies across healthcare are validating the need for size and scale," said George Paz, Chairman and Chief Executive Officer. "But, what matters most is how that size and scale is leveraged. In our case, that means creating a business model fully aligned with client needs. By aligning our interests with those of our patients and clients our scale is focused on driving down costs while improving health outcomes. Our focused size and scale helps us make prescription drugs safer and more affordable which benefits everyone in healthcare -- patients, plan sponsors and medical professionals. We are pleased with our second quarter results and outperforming our guidance. Our results are a testament to our model of driving performance through our focused scale and alignment."

Help employers find you! Check out all the jobs and post your resume.

Back to news